S4754 (2023-24 session)
NY State bill
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
- Title
- Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- In Senate Committee
- Latest action date
- 2024-01-03
- In committee
- Insurance
- Introduced
- 2023-02-14
- Law section
- Insurance Law
Sponsors
- Andrew J. Lanza State Senator, District 24
Heard in committee
- Insurance NY State Senate committee